Sorbitol for Health & Longevity - Quick Reference Sheet

Sorbitol for Health & Longevity

Created on 08/21/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 Audit

Sorbitol is both a sweetener people eat and a substance the body makes. It softens stool and moves it through the gut faster, raises blood sugar far less than table sugar, and modestly reduces tooth decay. Bloating and loose stool follow predictably above roughly 10 to 20 grams daily. It also reduces absorption of some swallowed medicines. (Full Review)

Protocol

Standard laxative protocol
15 to 30 mL of 70% solution once daily
About 10 to 21 g by mouth, titrated to Bristol stool form 3 to 4, then reduced once regularity holds
Single versus split dosing
Split above 10 g daily
Keeps each bolus under the malabsorption threshold and markedly reduces flatulence without reducing total laxative effect
Best time of day
Evening for laxative use
Onset of 6 to 24 hours produces a morning bowel movement; sweetener use is best spread across meals
Time to effect
Laxative effect
6 to 24 hours
From the first adequate dose
Dental effects
Months
Habitual daily use; measured over trial periods of one to three years
Microbiome effects
Months
Habitual daily use at moderate doses

Benefits

Contraindications
  • Hereditary fructose intolerance (both ALDOB gene copies faulty), at any dose, including as a medicine excipient
  • Sorbitol dehydrogenase deficiency (both SORD gene copies faulty)
  • Established or suspected bowel obstruction, ileus, or acute severe colitis
  • Chronic kidney disease at stage 4 or worse with a concurrent polystyrene sulfonate resin
  • Severe diarrhoea-predominant irritable bowel syndrome with a positive sorbitol breath test
  • Sodium or calcium polystyrene sulfonate with reduced bowel motility
Key Interactions
  • Ranitidine and other rapidly absorbed oral drugs
  • Loop and thiazide diuretics (furosemide, hydrochlorothiazide)
  • Digoxin
  • Other osmotic laxatives (lactulose, polyethylene glycol 3350, magnesium hydroxide)
  • Magnesium and vitamin C supplements at high dose
  • Fructose-containing and other polyol-containing foods
  • Prebiotic fibre supplements (inulin, fructooligosaccharides)
  • Metformin

Risk & Side Effects

  • High: Dose-dependent bloating, flatulence and osmotic diarrhea
  • Medium: Reduced absorption of co-administered oral medicines; higher circulating polyols and coronary heart disease
  • Low: Bowel necrosis with sodium polystyrene sulfonate preparations; acute metabolic crisis in hereditary fructose intolerance; fluid and electrolyte loss with sustained laxative dosing
  • Speculative: Expansion of sorbitol-utilising Clostridioides difficile; added contribution to tissue polyol load

Monitoring

Marker Target Why
Bristol Stool Form Score 3 to 4 Primary success measure for laxative use
Serum potassium 4.0 to 4.5 mmol/L Detects osmotic potassium loss
Serum sodium 138 to 142 mmol/L Detects dehydration from fluid shift
eGFR Above 90 mL/min/1.73 m² Sets tolerance for fluid and electrolyte loss
Fasting blood glucose 70 to 85 mg/dL (3.9 to 4.7 mmol/L) Confirms benefit of substituting sorbitol for sugar
HbA1c 4.8 to 5.4% Confirms the substitution held over time
Sorbitol hydrogen breath test, peak rise Below 20 ppm above baseline Identifies malabsorbers needing half doses
Fasting plasma sorbitol No established consumer target; track change from the individual's own baseline Relevant only where SORD deficiency is suspected

Cadence: Symptoms and stool form weekly during titration, then monthly. Electrolytes and kidney function at four weeks of daily laxative-range dosing, then every six to twelve months, and more often alongside diuretics. HbA1c at three months where sugar substitution is the goal.

Qualitative Assessment

  • Bloating and abdominal distension, scored 0 to 10 daily during titration
  • Flatulence frequency and whether it disrupts work or sleep
  • Urgency and any episode of incontinence, which indicates the dose is too high
  • Straining and sense of incomplete evacuation, the symptoms the laxative use targets
  • Energy and cognitive clarity, as proxies for adequate hydration during sustained dosing
  • Dental sensitivity and gum bleeding, where sugar substitution is the goal